968 



INDEX 



Suprarenal extracts, intravenous injec- 

 tions of, Oliver and Schafer's experi- 

 ments on, effects of, 28. 



See also Suprarenals, hormonother- 

 apy of, and organotherapy of. 



Suprarenal function, tonus theory of, 

 16. 



Suprarenal glycosuria, action of epi- 

 nephrin on, pharmacodynamic, 127. 



Suprarenal insufficiency, acute, supra- 

 renal therapy for, 132. 



functional, suprarenal therapy for, 

 134. 



Suprarenal secretion, control of, 168. 



Suprarenal therapy, epinephrin an 

 active principle rather than the ac- 

 tive principle of gland, 9. 



Suprarenal tissue, outlying, 40. 



Suprarenals, Addison's disease pro- 

 duced by removal of Brown-Sequard's 

 experiments (1856), 60. 



Addison's monograph on supra- 

 renals, in common with spleen, thy- 

 mus and thyroid body, ministering 

 to the elaboration of the blood, 55. 



Addison's monograph "On the Con- 

 stitutional and Local Effects of Dis- 

 ease of," 54. 



antispastic action of epinephrin, 138. 



autonomic system and, control of 

 suprarenal secretion, 168. 



epinephrin, control of, 168. 



pharmacodynamic action of, 

 167. 



sympathetic system and, 167. 



relation to glycosuria, 168. 



relation to vascular system, 169. 



deficiency of, resulting in muscular 

 and circulatory weakness, 42. 



diseased condition of, and pernicious 

 anemia, 54. 



empiric action of epinephrin, 140. 



hormonotherapy of, antispastic ac- 

 tion of, 138. 



antispastic action, in bronchial 

 asthma, 138. 



in diarrhea, 140. 



in stenosis of esophagus, 140. 



in vomiting, 139. 



empiric, bone diseases, 140. 



epinephrin and the arsenical 

 antisyphilitic preparations, 140. 



undesirable results and con- 

 tradictions, 141. 



pharmacodynamic, 124. See also 

 Epinephrin. 



symptomatic, 134. 



Suprarenals, hormonotherapy of, symp- 

 tomatic, vasoconstricting action, 134. 



vasoconstricting action, 134. 



in alimentary canal, 136. 



in eye, 136. 



in genito-urinary tract, 136. 



in hemorrhage, accessible, 135, 



136. 



inaccessible, 137, 138. 



local anesthesia, 135. 



mouth and upper air passages, 



135. . 



remote or systemic, 137. 



skin affections, 138. 



in senescence, 23. 



organotherapy of, 131. 



in acute suprarenal insufficiency 



(acute hypoadrenia), 132. 



in Addison's disease, 131. 



in circulatory failure of infec- 

 tious diseases, 132. 



in collapse of infectious diseases, 



133. 



in Erb's myasthenia, 134. 



in suprarenal insufficiency (hypo- 

 adrenia), 134. 



pharmacodynamic action of epineph- 

 rin, 124. See also Epinephrin. 



relation of, to glycosuria, 168. 

 to vascular system, 169. 



symptomatic therapy with, 134. 



vasoconstricting action of epineph- 

 rin, 134. 



Sympathectomy for exophthalmic goi- 

 ter, 375. 



Sympathetic and parasympathetic hy- 

 perirritability in Graves' disease, 172. 



Sympathetic hyperirritability. See 

 Sympathicotonia. 



Sympathetic system, changes in ganglia 

 of, in Graves' disease, 173. 



relationship of epinephrin to, 167. 



thyroid relationship to, clinical sig- 

 nificance of, 171. 



Sympathicotonia, definition and physi- 

 ology of, 164. 



manifestations of, 165. 



variability of symptomatology as 

 clinically seen, 166. 



Synapse, 73. 



Syphilis, as cause of exophthalmic goi- 

 ter, 308. 



causing dystrophia adiposogenitalis, 

 904. 



'of hypophysis cerebri, 784. 



parathyroid involvement in, 564. 



thyroid treatment in, 103. 



